Kentaro Tanaka Selected Research

Transcription Factor 3

12/2021

Standard therapy-resistant small cell lung cancer showing dynamic transition of neuroendocrine fate during the cancer trajectory: A case report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kentaro Tanaka Research Topics

Disease

34	Neoplasms (Cancer) 05/2022 - 03/2011
32	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2022 - 10/2010
8	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2021 - 04/2011
7	Lung Neoplasms (Lung Cancer) 07/2021 - 04/2011
5	Neoplasm Metastasis (Metastasis) 12/2021 - 01/2013
4	Disease Progression 01/2021 - 01/2020
4	Pleural Effusion (Pleural Effusions) 12/2019 - 07/2018
3	Cardiovascular Diseases (Cardiovascular Disease) 06/2022 - 12/2015
3	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 05/2021
3	Anorexia 01/2022 - 10/2019
3	Infections 12/2021 - 03/2011
3	Adenocarcinoma of Lung 01/2020 - 01/2018
3	Type 2 Diabetes Mellitus (MODY) 06/2016 - 11/2013
3	Asthma (Bronchial Asthma) 06/2012 - 05/2006
2	Chronic Renal Insufficiency 04/2022 - 01/2022
2	Edema (Dropsy) 01/2022 - 01/2019
2	Hypovolemia 01/2022 - 01/2020
2	Connective Tissue Diseases (Connective Tissue Disease) 01/2020 - 01/2020
2	Sarcoidosis (Schaumann Disease) 01/2020 - 09/2005
2	Thrombosis (Thrombus) 06/2019 - 12/2015
2	Arthralgia (Joint Pain) 03/2019 - 01/2018
2	Anemia 01/2019 - 01/2018
2	Iron Deficiencies 01/2018 - 01/2018
2	Atherosclerotic Plaque (Atheroma) 01/2018 - 01/2015
2	Pain (Aches) 01/2018 - 05/2016
2	Carcinoma (Carcinomatosis) 10/2017 - 05/2016
2	Melanoma (Melanoma, Malignant) 08/2016 - 01/2013
2	Inflammation (Inflammations) 12/2014 - 06/2012
2	Hyperuricemia 12/2014 - 06/2011
2	Eosinophilia 06/2012 - 05/2006
1	Wound Infection (Wound Infections) 10/2022
1	Cerebrospinal Fluid Leak 10/2022
1	Weight Gain 01/2022
1	Constipation 01/2022
1	Cachexia 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Drug-Related Side Effects and Adverse Reactions 01/2022
1	Neuralgia (Stump Neuralgia) 09/2021

Drug/Important Bio-Agent (IBA)

13	Immune Checkpoint InhibitorsIBA 01/2022 - 07/2018
11	ErbB Receptors (EGF Receptor)IBA 01/2021 - 06/2013
10	Tyrosine Kinase InhibitorsIBA 01/2021 - 06/2013
6	LigandsIBA 01/2022 - 11/2017
6	osimertinibIBA 12/2021 - 01/2021
5	PlatinumIBA 01/2022 - 12/2018
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 06/2013
4	NivolumabIBA 01/2022 - 08/2016
3	Proteins (Proteins, Gene)FDA Link 04/2022 - 01/2018
3	pembrolizumabIBA 01/2022 - 10/2017
3	Pharmaceutical PreparationsIBA 01/2022 - 07/2018
3	Carboplatin (JM8)FDA LinkGeneric 12/2021 - 01/2021
3	Transcription Factors (Transcription Factor)IBA 12/2021 - 01/2020
3	Uric Acid (Urate)IBA 01/2021 - 06/2011
3	Pemetrexed (MTA)FDA Link 01/2021 - 01/2020
3	AfatinibIBA 11/2020 - 09/2017
3	Monoclonal AntibodiesIBA 01/2020 - 06/2012
3	CytokinesIBA 12/2019 - 06/2008
3	NeuropeptidesIBA 10/2019 - 05/2006
3	Hemoglobins (Hemoglobin)IBA 01/2018 - 06/2016
2	omega-Chloroacetophenone (Mace)IBA 06/2022 - 12/2015
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2022 - 01/2022
2	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2022 - 01/2020
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2022 - 07/2018
2	Sorafenib (BAY 43-9006)FDA Link 01/2022 - 05/2021
2	Etoposide (VP 16)FDA LinkGeneric 12/2021 - 12/2018
2	atezolizumabIBA 12/2021 - 01/2020
2	AlbuminsIBA 05/2021 - 01/2021
2	Cisplatin (Platino)FDA LinkGeneric 07/2020 - 05/2016
2	Immune Checkpoint ProteinsIBA 01/2020 - 12/2019
2	AntibodiesIBA 12/2019 - 01/2019
2	delta proteinIBA 01/2019 - 01/2018
2	rovalpituzumab tesirineIBA 01/2019 - 01/2018
2	Immunoconjugates (Immunoconjugate)IBA 01/2019 - 01/2018
2	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2017 - 12/2014
2	AllergensIBA 06/2012 - 05/2006
2	Interleukin-13IBA 06/2012 - 06/2009
1	PlasticsIBA 10/2022
1	enhanced green fluorescent proteinIBA 01/2022
1	IpilimumabIBA 01/2022
1	Ghrelin ReceptorsIBA 01/2022
1	ClusterinIBA 01/2022
1	anamorelinIBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	lenvatinibIBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2021
1	Neurogenic differentiation factor 1IBA 12/2021
1	Transcription Factor 3IBA 12/2021
1	130-nm albumin-bound paclitaxelIBA 12/2021
1	Cell-Free Nucleic AcidsIBA 07/2021

Therapy/Procedure

23	Therapeutics 05/2022 - 09/2005
8	Drug Therapy (Chemotherapy) 06/2021 - 04/2011
5	Renal Dialysis (Hemodialysis) 01/2021 - 09/2005
3	Radiotherapy 12/2021 - 03/2011
3	Ligation 09/2021 - 09/2017
3	Stents 11/2019 - 12/2015
3	Glycemic Control 06/2016 - 11/2013
2	Immunotherapy 05/2022 - 01/2021
2	Free Tissue Flaps 12/2021 - 09/2013
2	Lymph Node Excision (Lymph Node Dissection) 08/2016 - 01/2013
1	Combination Drug Therapy (Combination Chemotherapy) 01/2022
1	Operative Surgical Procedures 12/2021